Active Ingredient History
In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Febrile Encephalopathy (Phase 2)
Adenocarcinoma, Clear Cell (Phase 1)
Adrenoleukodystrophy (Phase 2/Phase 3)
Allografts (Phase 1/Phase 2)
Alopecia (Phase 2)
alpha-Mannosidosis (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Anemia, Aplastic (Phase 2/Phase 3)
Anemia, Diamond-Blackfan (Phase 2/Phase 3)
Anemia, Sickle Cell (Phase 3)
Arterial Occlusive Diseases (Phase 2)
Arthritis, Rheumatoid (Phase 1/Phase 2)
Aspartylglucosaminuria (Phase 2)
Astrocytoma (Early Phase 1)
Autism Spectrum Disorder (Phase 1/Phase 2)
Autistic Disorder (Phase 1/Phase 2)
Azoospermia (Phase 1/Phase 2)
Bone Marrow Cells (Phase 1/Phase 2)
Bone Marrow Transplantation (Phase 3)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Bulbar Palsy, Progressive (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiomyopathy, Dilated (Phase 2/Phase 3)
Cerebral Palsy (Phase 1/Phase 2)
Chagas Cardiomyopathy (Phase 3)
Chediak-Higashi Syndrome (Phase 2/Phase 3)
Choriocarcinoma (Phase 3)
Corneal Diseases (Phase 1)
Coronary Artery Disease (Phase 1)
Coronary Disease (Phase 1/Phase 2)
Crohn Disease (Phase 1/Phase 2)
Deficiency Diseases (Phase 2)
Diabetes Mellitus (Phase 2/Phase 3)
Dyskeratosis Congenita (Phase 2/Phase 3)
Endodermal Sinus Tumor (Phase 3)
Ependymoma (Early Phase 1)
Fanconi Anemia (Phase 1/Phase 2)
Fucosidosis (Phase 2/Phase 3)
Gangliosidosis, GM1 (Phase 2/Phase 3)
Gaucher Disease (Phase 2/Phase 3)
Genetic Diseases, Inborn (Phase 2)
Germinoma (Phase 3)
Glioma (Early Phase 1)
Graft vs Host Disease (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Hair (Phase 2/Phase 3)
Heart Failure (Phase 2/Phase 3)
Hematologic Diseases (Phase 2/Phase 3)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cells (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinopathies (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 3)
Histiocytosis, Langerhans-Cell (Phase 2/Phase 3)
Hodgkin Disease (Phase 2)
Immune System Diseases (Phase 2/Phase 3)
Immunoglobulin Light-chain Amyloidosis (Phase 3)
Immunologic Deficiency Syndromes (Phase 2)
Infertility, Male (Phase 1/Phase 2)
Intellectual Disability (Phase 1)
Intestinal Neoplasms (Phase 1)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Lymphoid (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 1/Phase 2)
Leukodystrophy, Globoid Cell (Phase 2/Phase 3)
Leukodystrophy, Metachromatic (Phase 2/Phase 3)
Liver Cirrhosis (Phase 1/Phase 2)
Liver Neoplasms (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1/Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1/Phase 2)
Lymphoproliferative Disorders (Phase 2/Phase 3)
Mannosidase Deficiency Diseases (Phase 2)
Melanoma (Phase 1)
Mesenchymal Stem Cell Transplantation (Phase 2)
Metabolic Diseases (Phase 2)
Motor Neuron Disease (Phase 1/Phase 2)
Mucopolysaccharidoses (Phase 2/Phase 3)
Mucopolysaccharidosis I (Phase 2)
Mucopolysaccharidosis II (Phase 2)
Mucopolysaccharidosis VI (Phase 2)
Mucopolysaccharidosis VII (Phase 2)
Mucositis (Phase 1/Phase 2)
Multiple Myeloma (Phase 4)
Muscular Atrophy, Spinal (Phase 1/Phase 2)
Muscular Dystrophies (Phase 1/Phase 2)
Muscular Dystrophies, Limb-Girdle (Phase 1)
Muscular Dystrophy, Duchenne (Phase 1/Phase 2)
Mutation (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 1/Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 2/Phase 3)
Neuronal Ceroid-Lipofuscinoses (Phase 2/Phase 3)
Neutropenia (Phase 2/Phase 3)
Niemann-Pick Diseases (Phase 2/Phase 3)
Niemann-Pick Disease, Type B (Phase 2)
Niemann-Pick Disease, Type C (Phase 2)
Oligodendroglioma (Early Phase 1)
Optic Atrophy (Phase 1/Phase 2)
Optic Nerve Diseases (Phase 1/Phase 2)
Optic Nerve Glioma (Early Phase 1)
Osteoarthritis (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 2)
Osteopetrosis (Phase 2/Phase 3)
Ovarian Diseases (Phase 1)
Ovarian Neoplasms (Phase 2)
Pain (Phase 1/Phase 2)
Paraproteinemias (Phase 1/Phase 2)
Peripheral Blood Stem Cell Transplantation (Phase 1/Phase 2)
Peroxisomal Disorders (Phase 2)
Plasmacytoma (Phase 2)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Preleukemia (Phase 1/Phase 2)
Pressure Ulcer (Phase 1)
Primary Immunodeficiency Diseases (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 1)
Primary Ovarian Insufficiency (Phase 1/Phase 2)
Pulpitis (Phase 3)
Refsum Disease, Infantile (Phase 2)
Retinoblastoma (Phase 1)
Rhabdoid Tumor (Phase 1)
Rhabdomyosarcoma (Phase 1)
Sandhoff Disease (Phase 2/Phase 3)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)
Sarcoma, Myeloid (Phase 2)
Scleroderma, Systemic (Phase 2)
Seminoma (Phase 3)
Severe Combined Immunodeficiency (Phase 1)
Shwachman-Diamond Syndrome (Phase 2/Phase 3)
Sphingolipidoses (Phase 2)
Sphingomyelins (Phase 2)
ST Elevation Myocardial Infarction (Phase 2)
Stem Cell Transplantation (Phase 2)
Stomatitis (Phase 1/Phase 2)
Stroke (Phase 1/Phase 2)
Supranuclear Palsy, Progressive (Phase 1/Phase 2)
Tay-Sachs Disease (Phase 2/Phase 3)
Temporomandibular Joint Disorders (Phase 1/Phase 2)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 2)
Thalassemia (Phase 2/Phase 3)
Transplantation (Phase 3)
Urological Manifestations (Phase 1)
Urologic Diseases (Phase 2/Phase 3)
Waldenstrom Macroglobulinemia (Phase 2/Phase 3)
Wilms Tumor (Phase 1)
Wiskott-Aldrich Syndrome (Phase 1/Phase 2)
Wolman Disease (Phase 2/Phase 3)
Wound Healing (Phase 1)
Wounds and Injuries (Phase 1)
Xerostomia (Phase 2)
Zellweger Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
